At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Columbia based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.

Tim Schaller
Chief Financial Officer of New Enterprise Associates
Tim Schaller joined NEA in 2008 as Chief Financial Officer and is responsible for finance, investment operations, facilities, and information technology. Prior to joining NEA, Tim was Chief Financial Officer at Algenol Biofuels Inc., a Florida-based alternative energy company. He began his career at PricewaterhouseCoopers (C&L), where he was a Manager specializing in financial services. Tim earned his bachelor’s degree in accounting from Loyola College of Maryland and his master’s degree concentrating in financial management from Johns Hopkins University.
Follow Tim Schaller:
About New Enterprise Associates: New Enterprise Associates is a global venture capital firm investing in technology and healthcare.

Nizar Bharmal
Chief Financial Officer of Aurin Biotech
Nizar Bharmal is a renowned Certified General Accountant with over 30 years of well-merited accomplishments in his field. He was granted the professional designation of CGA in 1980. Early in his career he worked in the real estate development and investment field. From 1982 until 1985 Mr. Bharmal was Manager of the Bomarc Group, a management company providing services for reporting companies. In 1985, Mr. Bharmal passed the Canadian Securities Course with honors and founded Nizar Bharmal Inc. as a public practice dedicated to providing an array of accounting services, including Canadian and US taxation, financial consulting and corporate management for reporting companies. During his career, he has served as CEO and CFO for several publicly listed companies, where he has gained deep insight into both operations and regulatory affairs. Mr. Bharmal’s extensive association with and commitment to local business communities has resulted in admiration and confidence from many of his colleagues.
Follow Nizar Bharmal:
About ArcPacific Resources, Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.

Dane Saglio
CFO of Helomics
Dane Saglio serves as Chief Financial Officer of Helomics®. Formerly, Mr. Saglio was the CFO of RegeneRx Biopharmaceuticals, Inc; SuperNova Diagnostics; New Generation Biofuels; EntreMed Biopharmaceuticals; and held senior financial positions with Sterling Software, Inc. and Public Communication Associates. Mr. Saglio also has extensive public and private company experience along with a wide range of corporate finance and strategic transactions experience. Dane earned his B.S. in business administration from the University of Maryland and is a licensed CPA (inactive).
Follow Dane Saglio:
About Helomics, RegeneRx: Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.

Laurie Silver
Chief Financial Officer of BrainScope Company
Laurie Silver has over 20 years’ experience with a financial, accounting, strategic planning and operations background. Prior to BrainScope, she served as Director of Mergers and Acquisitions for the Services group at Symantec, where she led the integration of the Services organizations upon the $13 billion merger of Symantec and Veritas, which was the largest software company merger in history. Prior to Symantec, Ms. Silver was the Vice President of Finance and Administration of TrueCareers, a subsidiary of Sallie Mae; Manager of Financial Planning and Analysis across all business units of ABC/Disney; and a Senior Auditor at Ernst & Young LLP in New York. Ms. Silver graduated from the Stephen M. Ross School of Business at the University of Michigan and earned a CPA license from the State of New York. She has been with BrainScope since 2009.
Follow Laurie Silver:
About BrainScope Company: Brainscope is a medical neurotechnology company that improves brain health.

Richard Lindahl
Executive Vice President & Chief Financial Officer of Emergent BioSolutions
Rich Lindahl currently serves as the executive vice president and chief financial officer at Emergent BioSolutions.
Follow Richard Lindahl:
About Corporate Executive Board (CEB), Emergent BioSolutions: Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.
Douglas J. Swirsky
Chief Financial Officer of AavantiBio
Follow Douglas J. Swirsky:
About AavantiBio, TrAMPoline Pharma: AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Simon Buckett
CFO of HealthTech Connex
Mr. Buckett brings with him over twelve years of finance and project management experience working for private and publicly listed companies in the UK, US, and Canada. Mr. Buckett began his career with KPMG in London and then in Vancouver as Senior Auditor, later joining Ernst & Young as an audit department Manager. Most recently he was Vice President of Finance at Wurldtech Security Technologies, Inc. His responsibilities have included internal control and governance policy, the implementation of Sarbanes-Oxley in a number of SEC registrants, and managing the reporting requirements of a range of private and public companies.
Follow Simon Buckett:
About HealthTech Connex: HealthTech Connex focuses on technology-based innovations for health improvements and outcomes.

Raymond Bryan
Chief Financial Officer and Chief Administrative Officer of The American Chemistry Council (ACC)
As CFO and Chief Administrative Officer of the American Chemistry Council (ACC), Mr. O’Bryan oversees the Accounting and Finance, Human Resources, Information Technology, Economic and Statistics and CHEMTREC® Divisions. These groups provide strategic planning, information management and back-office administrative services that support the Council’s programs, enhance advocacy and provide member value. Additionally, he serves as Plan Administrator for all pension and welfare benefit plans sponsored by the Council. Mr. O’Bryan joined the Council in 1985 as Assistant Controller and progressed up the Council’s management ranks, becoming ACC’s Vice President and Treasurer in 1998. He has nearly 30 years of experience in the financial management and reporting arenas, with 25 years here at ACC. Prior to coming to ACC, Ray held positions as an internal auditor with DynCorp. and in public accounting with a Washington, D.C.-based public accounting firm specializing in not-for-profit organizations. He is a member of the American Institute of Certified Public Accountants and the Greater Washington Society of CPA’s. Mr. O’Bryan received his bachelor’s degree in accounting from the University of South Carolina.
Follow Raymond Bryan:
About The American Chemistry Council (ACC): The American Chemistry Council (ACC) represents the leading companies in the business of chemistry.

Thomas Kordyback
Chief Financial Officer of RepliCel Life Sciences
Tom Kordyback is a Chartered Accountant and a member of the British Columbia Institute of Chartered Accountants with over 25 years of experience in corporate finance and management for emerging growth companies. From 1984 to 1994, he held senior financial positions with Glenayre Electronics Inc. and Telelink Communications Inc. and worked as a consultant to other Vancouver area companies. In 1995, he began working for Creo, now part of Eastman Kodak Company as their Chief Financial Officer. In this role he oversaw private financings totally over $80 million and in 1999 he led the company’s Initial Public Offering on NASDAQ. He remained at Creo until 2000; at which time, the company had over 4000 employees worldwide. In 2004, Mr. Kordyback joined Extreme CCTV Inc., a developer and manufacturer of state-of-the-art surveillance systems listed on the TSX. He worked for them for three years as a director and member of its Audit, Compensation and Merger and Acquisitions Committees. In 2008 the company was sold to Bosch Security Systems, Inc. for CDN $93 million. Mr. Kordyback currently serves as a director of Silver Sun Resources Corp., a public Canadian-based resource company.
Follow Thomas Kordyback:
About RepliCel Life Sciences: RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.
Ann Fehr
CFO of Aequus Pharmaceuticals
Fehr is the Principal at Fehr & Associates, and has held a number of senior level positions including having served as CFO of Carrus Capital Corporation (formerly BioWest Therapeutic Inc.), Global Minerals Ltd., and other companies listed on the TSX. During the course of her management and consulting career, Ms. Fehr has led a number of companies through significant change and corporate milestones such as public listing applications, mergers and acquisitions, as well as strategic planning and execution. Ms. Fehr is also an active volunteer in the community. Since 2013, she has been Treasurer and a Director for the Boys and Girls Clubs of South Coast BC.
Follow Ann Fehr:
About Aequus Pharmaceuticals: Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.

Akmal Jameel
Chief Financial Officer of Fusion Genomics Corporation
Follow Akmal Jameel:
About Fusion Genomics Corporation, SensoDrive Technology: Fusion Genomics develops highly sensitive and massively multiplex DNA/RNA sequencing based diagnostics for infectious diseases.

Corbin Director
CFO of RxAnte
Prior to joining RxAnte, Mr. Director was a venture capitalist at Radius Ventures where he concentrated on executing development and growth stage investments in the healthcare information technology, healthcare services, and medical technology sectors. He was also previously an investment banker at B.C. Ziegler & Co. where he specialized in healthcare M&A and private placement transactions. Mr. Director earned a BA in Physical Science from Colgate University and an MBA from the Wharton School at the University of Pennsylvania.
Follow Corbin Director:
About RxAnte: RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.

George Dorin
Chief Financial Officer & Corporate Secretary of Pyng Medical
Mr. Dorin has 30 years of broad-based financial experience, including 15 years as a Corporate Director or CFO for several private and public companies. He holds undergraduate degrees in Science and Accounting from the University of BC, a Masters Degree in Finance from the London School of Economics, and the Diploma FCSI (Fellow of the Canadian Securities Institute). A Chartered Accountant, he was also granted a CF (Corporate Finance) specialist designation from the CICA in 2008. Prior to his work in industry, he worked in the financial services sector with Ernst & Whinney (now KPMG), Price Waterhouse, Royal Bank of Canada, and with Pemberton Securities (now RBC Dominion Securities). In 2007 and 2008 he was a Senior VP Corporate Finance at Wolrige Mahon, a BC-based CA Firm. Most recently, he has been providing corporate finance, senior financial management and corporate director (including audit committee chairman) services to several industrial public companies through this own company CANUS Capital Corporation.
Follow George Dorin:
About Pyng Medical: Pyng Medical develops trauma and resuscitation products for the health care industry.
Cameron Nelson
CFO of Mati Therapeutics
Cameron Nelson is the CFO at Mati Therapeutics.
Follow Cameron Nelson:
About Mati Therapeutics: Mati Therapeutics offers a delivery system to deliver drugs to the surface of the eye through the tear film.
Cameron Nelson
CFO of Mati Therapeutics
Cameron Nelson is the CFO at Mati Therapeutics.
Follow Cameron Nelson:
About Mati Therapeutics: Mati Therapeutics offers a delivery system to deliver drugs to the surface of the eye through the tear film.

Eric Booth
Chief Financial Officer of Heart Rhythm Society
Follow Eric Booth:
About Heart Rhythm Society: Heart Rhythm Society provides professional programs and education to develop healthcare policies and patient care.

Bruce Colwill
CFO of InMed Pharmaceuticals
Bruce Colwill is the Chief Financial Officer at InMed Pharmaceuticals.
Follow Bruce Colwill:
About InMed Pharmaceuticals: InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.